首页> 外文期刊>Journal of International Medical Research >1470?nm/980?nm dual-wavelength laser is safe and efficient for the en-bloc resection of non-muscle invasive bladder cancer: A propensity score-matched analysis
【24h】

1470?nm/980?nm dual-wavelength laser is safe and efficient for the en-bloc resection of non-muscle invasive bladder cancer: A propensity score-matched analysis

机译:1470?NM / 980?NM双波长激光器对于<斜体切换=“是”> en-Bloc 切除非肌肉侵入性膀胱癌:倾向分数匹配分析

获取原文
           

摘要

Objective To evaluate the efficacy and safety of a 1470?nm/980?nm dual-wavelength laser system used for the en-bloc resection of non-muscle invasive bladder cancer (NMIBC) compared with transurethral resection of bladder tumour (TURBT). Methods This retrospective study analysed the demographic and clinical data from patients diagnosed with NMIBC that were treated by either dual laser or TURBT. Intraoperative characteristics, postoperative characteristics and outcomes between the two groups were compared. Results This study analysed 64 patients, 32 in each group. No severe complications were identified in either group. After propensity score-matching, there were no significant differences between the two groups in terms of the demographics, clinical and tumour characteristics. There was no significant difference between the two groups in terms of specimen quality. In the laser group, intraoperative blood loss was significantly lower and significantly fewer patients required continuous bladder irrigation after surgery, compared with the TURBT group. No significant differences were observed in the catheterization time, gross haematuria time and hospitalization time. Operation time in the laser group was significantly longer compared with the TURBT group. No significant difference was found in the recurrence and progression rates between the two groups. Conclusions The 1470?nm/980?nm dual-wavelength laser provides a safe and effective surgical treatment option for patients with NMIBC.
机译:目的评价1470?NM / 980?NM双波长激光系统的功效和安全性,与膀胱肿瘤经尿道切除术(TURBT)进行过肌肉侵袭性膀胱癌(NMIBC)。方法本回顾性研究分析了被诊断患有NMIBC的患者的人口统计和临床资料,所述NMIBC被双激光或TARBT治疗。比较了两组之间的术中特征,术后特征和结果。结果本研究分析了64名患者,每组32名。在任一组中没有发现严重的并发症。经过倾向分数匹配后,两组在人口统计学,临床和肿瘤特征方面没有显着差异。两组在标本质量方面没有显着差异。在激光组中,与TurBT组相比,术中失血显着降低,较少患者需要连续膀胱灌溉的患者。在导管插入时间内没有显着差异,总血尿时间和住院时间。与TurBT组相比,激光组中的操作时间明显更长。两组之间的复发和进展率没有显着差异。结论1470?NM / 980?NM双波长激光器为NMIBC患者提供了一种安全有效的手术治疗选择。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号